NA-Semax/NA-Selank Research Complex

NA-Semax/NA-Selank Research Complex

NA-Semax/NA-Selank Research Complex

NA-Semax/NA-Selank Research Complex

Selank & Semax (10MG/10MG) is a dual-heptapeptide reference blend combining the neurogenic actions of Semax (ACTH(4-10) derivative) with the anxiolytic and immunomodulatory properties of Selank (Tuftsin derivative). Semax upregulates Brain-Derived Neurotrophic Factor (BDNF) and stimulates TrkB receptor phosphorylation, while Selank allosterically modulates GABAA receptors and inhibits enkephalin-degrading enzymes.

Original price was: $78.00.Current price is: $58.50.

In stock

Purchase & earn 59 points!
Quantity Discounted Price
3 - 5 $56.16
7 - 10 $54.99
9 + $53.82

What is the NA-Semax/NA-Selank Research Complex?

The NA-Semax/NA-Selank Research Complex is a dual-heptapeptide analytical formulation combining two of the most widely investigated synthetic regulatory peptides in neuro-biochemical research: Semax (10MG) and Selank (10MG). Developed to study synergistic central nervous system modulation, this combination couples an adrenocorticotropic hormone fragment analogue with an extended tuftsin immunomodulatory analogue.

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) acts primarily as a cognitive and neuro-restorative peptide, upregulating Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) while stimulating TrkB receptor cascades and optimizing dopaminergic/serotonergic turnover. Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) functions as an allosteric modulator of GABAA receptor complexes, inhibiting endogenous enkephalin breakdown to attenuate anxiety-like stress responses without sedative depression.

In modern neurochemical modeling, researchers evaluate standard unmodified sequences alongside specialized terminal modifications, including N-Acetyl Semax (NA-Semax), N-Acetyl Selank (NA-Selank), amidated versions, dual-modified NA-Semax Amidate (NA-Semax-Amidate) and NA-Selank Amidate (NA-Selank-Amidate), and advanced adamantyl-conjugated derivatives such as Adamax and Adalank.

Batch-verified for high analytical purity at Modern Aminos, this complex is supplied as a lyophilized dry solid in a 2R glass vial. Investigators study this dual-peptide matrix alongside complementary neuro-active standards available on the site, such as Nooglutyl, Bromantane, 9-Me-BC, and NSI-189 Phosphate.

Chemical and Molecular Data

Parameter Semax Component Selank Component
Compound Name Semax (ACTH(4-10) Analogue) Selank (Tuftsin Analogue)
Vial Content 10MG Lyophilized Dry Powder 10MG Lyophilized Dry Powder
Peptide Sequence Met-Glu-His-Phe-Pro-Gly-Pro Thr-Lys-Pro-Arg-Pro-Gly-Pro
CAS Number 80714-61-0 129954-34-3
Chemical Formula C37H51N9O10S C33H57N11O9
Molecular Weight 813.92 g/mol 751.87 g/mol
Primary Target BDNF / TrkB & Dopaminergic Signaling GABAA Receptors & Enkephalinase Inhibition
Structure Class Synthetic Heptapeptide Analogue Synthetic Heptapeptide Analogue

What are the Mechanisms of Action?

The dual biochemical pathways and neuro-regulatory targets of NA-Semax/NA-Selank Research Complex in laboratory research include:

  • Semax: BDNF/TrkB Activation & Dopaminergic Neurotransmission: Semax triggers rapid transcriptional upregulation of Brain-Derived Neurotrophic Factor (BDNF) and its high-affinity receptor tropomyosin-related kinase B (TrkB) in hippocampal and cortical neurons. Concurrently, it stimulates striatal dopamine synthesis and modulates serotonin turnover without activating peripheral adrenocortical steroidogenesis.
  • Selank: GABAA Allosteric Modulation & Enkephalin Protection: Selank modulates the affinity of GABAA benzodiazepine-binding sites to normalize inhibitory tone under stress. Additionally, Selank competitively inhibits enkephalin-degrading enzymes (aminopeptidase N and neutral endopeptidase), preserving endogenous enkephalin signaling to provide anxiolytic and immunomodulatory activity.
  • Synergistic Neuro-Protection & Cytokine Suppression: Together, Semax and Selank modulate immune-inflammatory signaling by suppressing pro-inflammatory cytokine expression (such as IL-6) and protecting neuronal cell membranes from ischemic and oxidative degradation.

What do Preclinical & Academic Studies Show for Semax & Selank?

When evaluating research efficacy and published scientific literature for Semax & Selank:

  • Semax Neurotrophic Expression & Ischemic Rescue (PubMed): Biomedical studies cataloged on PubMed (PMID: 16997011) confirm that Semax rapidly upregulates BDNF and NGF expression in ischemic glial cell cultures, promoting neurite outgrowth and cellular survival.
  • Selank GABAergic Allosteric Kinetics & Anxiolysis (PMC): Comprehensive monographs archived in PMC (PMC4759318) document Selank’s capacity to alter GABAA receptor subunit expression, elevate enkephalin half-life, and regulate inflammatory cytokine production.
  • Chemical Profiling & Molecular Verification (PubChem): Official structural characterizations maintained on PubChem for Semax (CID: 3033959) and Selank (CID: 11957445) verify sequence fidelity, molecular masses (813.92 g/mol and 751.87 g/mol), and analytical retention parameters.

Structural Variations: Native vs. N-Acetyl vs. Amidate vs. Adamax / Adalank

In peptide chemistry, terminal end-capping and side-chain conjugations significantly alter enzyme degradation kinetics, lipophilicity, and membrane translocation:

Terminal Chemistry Distinctions (Acetylation, Amidation, & Adamantyl Modifications)

  • Unmodified / Native Standard: Features an unmodified N-terminus (free amine, H2N-) and C-terminus (free carboxyl, -COOH). Demonstrates immediate receptor engagement and classic pharmacokinetic clearance profiles.
  • N-Terminal Acetylated (NA-Semax / NA-Selank / N-Acetyl Semax / N-Acetyl Selank): Capping the N-terminus with an acetyl group (Ac-) blocks cleavage by aminopeptidases. This increases plasma stability and raises the octanol-water partition coefficient, enhancing mucosal and blood-brain barrier penetration.
  • C-Terminal Amidated (Semax Amidate / Selank Amidate): Replacing the C-terminal hydroxyl with an amino group creates a carboxamide (-CONH2). This prevents degradation by carboxypeptidases and removes the negative charge at physiological pH, altering receptor residence time.
  • Dual-Modified (Adamax, Adalank, NA-Semax Amidate / NA-Selank Amidate / NA-Semax-Amidate / NA-Selank-Amidate): Combines both N-terminal acetylation and C-terminal amidation (Ac-[Sequence]-NH2). By capping both terminal ends, the peptide resists both aminopeptidases and carboxypeptidases, maximizing half-life in proteolytic environments.
Variant / Analogue Class N-Terminal State C-Terminal State Pharmacokinetic & Research Profile
Native / Standard (Offered Here) Free Amine (H2N-) Free Carboxyl (-COOH) Standard baseline reference; rapid clearance kinetics, zero synthetic terminal additions
N-Acetyl (NA-Semax / NA-Selank) Acetylated (Ac-) Free Carboxyl (-COOH) Protects against aminopeptidase cleavage; enhances lipophilicity and mucosal barrier transport
Amidate (Semax / Selank Amidate) Free Amine (H2N-) Amidated (-CONH2) Protects against carboxypeptidases; removes C-terminal negative charge for altered receptor kinetics
Dual-Capped (Adamax / Adalank / NA-Semax Amidate / NA-Selank Amidate) Acetylated (Ac-) Amidated (-CONH2) Full terminal protection; resists both amino- and carboxypeptidases for maximum in vitro half-life

Frequently Asked Questions (FAQs)

1. Is Modern Aminos a reliable place to buy NA-Semax/NA-Selank Research Complex?

Yes, Modern Aminos is a highly trusted vendor for high-purity research chemicals and reference peptides. Every batch of the Selank & Semax dual-peptide complex undergoes strict third-party analytical testing (including HPLC and Mass Spectrometry) to verify minimum 98%+ chemical purity for both heptapeptides, exact 10MG/10MG mass stoichiometry, correct molecular weights (Semax: 813.92 g/mol, Selank: 751.87 g/mol), and complete absence of synthesis impurities.

2. What is the NA-Semax/NA-Selank Research Complex formulation?

The NA-Semax/NA-Selank Research Complex is a combined analytical standard containing Semax (an ACTH(4-10) analogue) and Selank (a Tuftsin analogue) in a single lyophilized 2R glass vial designed for simultaneous neuro-chemical pathway evaluation.  There are versions that contain N-Acetylated, N-Acetyl-Amidated, non-Acetylated, and non-Amidate variations in this research blend to allow for different research

3. What are the primary mechanisms of action of Semax?

Semax stimulates the expression of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF), activates TrkB signaling cascades, and optimizes dopaminergic and serotonergic neurotransmission in cortical and hippocampal neural cell models.

4. What are the primary mechanisms of action of Selank?

Selank acts as an allosteric modulator of GABAA receptors to balance inhibitory neurotransmission and competitively inhibits enkephalin-degrading enzymes, prolonging endogenous enkephalin signaling to regulate stress and inflammatory pathways.

5. What is the difference between Native, N-Acetyl (NA), Amidate, and NA-Amidate versions of Semax and Selank?

Native versions possess unmodified N- and C-termini. N-Acetyl versions (NA-Semax / NA-Selank) feature an acetylated N-terminus to resist aminopeptidases. Amidated versions feature a C-terminal carboxamide (-CONH2) to resist carboxypeptidases. Dual-modified versions (NA-Semax Amidate / NA-Selank Amidate) contain both modifications (Ac-[Sequence]-NH2) for full enzymatic protection and extended biological stability.

6. What are Adamax and Adalank?

Adamax (an adamantane-modified Semax derivative) and Adalank (an adamantane-modified Selank derivative) are synthetic structural analogues featuring an attached adamantyl moiety. This lipophilic modification facilitates biological membrane penetration and extends central receptor occupancy in experimental models.

7. How does Modern Aminos verify the chemical purity and mass identity of dual-peptide vials?

Modern Aminos utilizes High-Performance Liquid Chromatography (HPLC) to resolve both peptide peaks and confirm 98%+ purity, combined with Mass Spectrometry (MS) to verify the individual molecular masses of Semax (813.92 g/mol) and Selank (751.87 g/mol) prior to batch release.

8. What are the recommended storage parameters for lyophilized NA-Semax/NA-Selank Research Complex glass vials?

Lyophilized NA-Semax/NA-Selank Research Complex glass vials should be stored tightly sealed in a cool, dry environment (15°C to 25°C) or refrigerated for long-term preservation. Protect from direct heat, light exposure, and atmospheric moisture to maintain solid-state peptide stability.

Disclaimer: All compounds and research materials provided by Modern Aminos are strictly for laboratory and research professional use only. They are not approved for human or animal use nor consumption by the Food and Drug Administration (FDA). These products should not be used for any form of in vivo experimentation or for any other non-laboratory purpose. Any violation or indication of human or animal use will result in immediate removal from being able to purchase products in the future. By purchasing these products, you acknowledge that they will be used exclusively within a controlled and qualified research environment.

The products offered by Modern Aminos are intended strictly for laboratory research purposes only and are sold exclusively to qualified professionals, institutions, and entities. These products are not for human consumption, veterinary use, or any other application involving living organisms, including but not limited to diagnostic, therapeutic, or recreational purposes.

By purchasing this product, you confirm that:

  • You are a qualified professional or entity with the necessary knowledge, training, and facilities to handle chemical reagents safely and appropriately.
  • You will use this product in full compliance with all applicable local, state, and federal laws and regulations.

Prohibited Uses

  • This product is not to be used as an active pharmaceutical ingredient (API) in compounding or manufacturing drugs for human or veterinary use.
  • It is strictly prohibited to use this product for administration to humans or animals under any circumstances.
  • Modern Aminos does not condone or permit the use of its products for the development, testing, or production of illegal substances.

Regulatory Compliance

Modern Aminos does not claim that this product is approved by the U.S. Food and Drug Administration (FDA) for any purpose. The statements regarding this product have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Liability Statement

The buyer assumes full responsibility for ensuring the safe handling, storage, and use of this product. Modern Aminos is not liable for any damages, direct or indirect, resulting from improper handling, storage, or unauthorized use of this product. Furthermore, Modern Aminos reserves the right to refuse sales to any individual or entity suspected of misusing its products.

If you have questions about the safe and lawful use of this product, consult a qualified professional with expertise in laboratory research. By proceeding with this purchase, you agree to these terms and conditions.

0